OJRM  Vol.1 No.3 , December 2012
Macrophage phenotypes correspond with remodeling outcomes of various acellular dermal matrices
ABSTRACT
Macrophages have recently been characterized as having an M1 or M2 phenotype based on receptor expression, mechanism of activation and function. The effects of macrophage phenotype upon tissue remodeling following implantation of an acellular dermal matrix (ADM) is largely unknown. The purpose of this study was to compare the macrophage phenotype and tissue remodeling elicited by four different ADMs (DermaMatrix, AlloDerm, Integra and Der mACELL). ADM samples were wrapped around the inferior epigastric vessels of a rat and were harvested on 7, 14, 21 and 42 days post implantation. Immunohistologic methods were used to identify macrophage surface markers CD68 (pan macrophage), CCR7 (M1 profile), and CD206 (M2 profile). All human derived ADMs showed a bell shaped curve for distribution of CD68+ macrophages with peaks for DermaMatrix occurring at day 14 and peak influx for AlloDerm occurring on day 21. In contrast, bovine derived Integra showed an increasing trend of macrophages with time. DermACELL had the highest influx of macro- phages while Integra had the lowest. A quantitative analysis of phenotype of macrophages in AlloDerm showed that the cells were predominantly M1 at 7, 14, 21 and 42 days post implantation. In contrast, Integra showed a mixed M1/M2 population of macrophages at all time points. The histopathologic evaluation showed that a predominantly M1 macrophage response was associated with a more inflamematory type tissue remodeling outcome in AlloDerm while a mixed M1/M2 macrophage response was associated with a more constructive tissue remodeling response seen in the other substrates.

Cite this paper
Agrawal, H., Tholpady, S., Capito, A., Drake, D. and Katz, A. (2012) Macrophage phenotypes correspond with remodeling outcomes of various acellular dermal matrices. Open Journal of Regenerative Medicine, 1, 51-59. doi: 10.4236/ojrm.2012.13008.
References
[1]   Lattari, V., Jones, L.M., Varcelotti, J.R., et al., (1997) The use of a permanent dermal allograft in full-thickness burns of the hand and foot: A report of three cases. Jour- nal of Burn Care & Rehabilitation, 18, 147-155. doi:10.1097/00004630-199703000-00010

[2]   Wainwright, D.J. (1995) Use of an acellular allograft der- mal matrix (AlloDerm) in the management of full- thickness burns, Burns, 21, 243-248. doi:10.1016/0305-4179(95)93866-I

[3]   Hartzell, T.L., Taghinia, A.H., Chang, J., et al. (2010) The use of human acellular dermal matrix for the correction of secondary deformities after breast augmentation: Results and costs. Plastic & Reconstructive Surgery, 126, 1711- 1720. doi:10.1097/PRS.0b013e3181ef900c

[4]   Tobin, H.A. and Karas, N.D. (1998) Lip augmentation us- ing an alloderm graft. Journal of Oral and Maxillofacial Surgery, 56, 722-727. doi:10.1016/S0278-2391(98)90805-9

[5]   Han, J.G., Wang, Z.J., Gao, Z.G., et al. (2010) Pelvic floor reconstruction using human acellular dermal matrix after cylindrical abdominoperineal resection. Diseases of the Colon & Rectum, 53, 219-223. doi:10.1007/DCR.0b013e3181b715b5

[6]   Kinsella Jr., C.R., Grunwaldt, L.J., Cooper, G.M., et al. (2010) Scalp reconstruction: Regeneration with acellular dermal matrix. Journal of Craniofacial Surgery, 21, 605- 607. doi:10.1097/SCS.0b013e3181d08cee

[7]   Garramone, C.E. and Lam, B. (2007) Use of AlloDerm in primary nipple reconstruction to improve long-term nip- ple projection. Plastic & Reconstructive Surgery, 119, 1663-1668. doi:10.1097/01.prs.0000258831.38615.80

[8]   Topol, B.M., Dalton, E.F., Ponn, T., et al. (2008) Imme- diate single-stage breast reconstruction using implants and human acellular dermal tissue matrix with adjustment of the lower pole of the breast to reduce unwanted lift. Annals of Plastic Surgery, 61, 494-499. doi:10.1097/SAP.0b013e31816d82d9

[9]   Anderson, J.M., Rodriguez, A. and Chang D.T. (2008) Foreign body reaction to biomaterials. Seminars in Im- munology, 20, 86-100. doi:10.1016/j.smim.2007.11.004

[10]   Valentin, J.E., Badylak, J.S., McCabe, G.P. and Badylak, S.F. (2006) Extracellular matrix bioscaffolds for ortho- paedic applications. A comparative histologic study. The Journal of Bone and Joint Surgery, 88, 2673-2686. doi:10.2106/JBJS.E.01008

[11]   Mosser, D.M. (2003) The many faces of macrophage activation. Journal of Leukocyte Biology, 73, 209-212. doi:10.1189/jlb.0602325

[12]   Mantovani, A., Sica, A. and Locati, M. (2005) Macro- phage polarization comes of age. Immunity, 23, 344-346. doi:10.1016/j.immuni.2005.10.001

[13]   Stout, R.D., Jiang, C., Matta, B., Tietzel, I., Watkins, S.K. and Suttles, J. (2005) Macrophages sequentially change their functional phenotype in response to changes in mi- croenvironmental influences. Journal of Immunology, 175, 342-349.

[14]   Kadl, A., Meher, A.K., Sharma, P.R., Lee, M.Y., Doran, A.C., Johnstone, S.R., et al. (2010) Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circulation Research, 107, 737-746. doi:10.1161/CIRCRESAHA.109.215715

[15]   Martinez, F.O., Helming, L. and Gordon, S. (2009) Al- ternative activation of macrophages: An immunologic fun- ctional perspective. Annual Review of Immunology, 27, 451-483. doi:10.1146/annurev.immunol.021908.132532

[16]   Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A. and Locati, M. (2004) The chemokine system in di- verse forms of macrophage activation and polarization. Trends in Immunology, 25, 677-686. doi:10.1016/j.it.2004.09.015

[17]   Stein, M., Keshav, S., Harris, N., et al. (1992) Interleukin 4 potently enhances murine macrophage mannose recep- tor activity: a marker of alternative immunologic macro- phage activation. The Journal of Experimental Medicine, 176, 287-292. doi:10.1084/jem.176.1.287

[18]   Dupasquier, M., Stoitzner, P., Wan, H., et al. (2006) The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononu- clear phagocytes, independent of IL-4/IL-13 signaling. Journal of Leukocyte Biology, 80, 838-849. doi:10.1189/jlb.1005564

[19]   Gilbert, T.W., Sellaro, T.L. and Badylak, S.F. (2006) De- cellularization of tissues and organs. Biomaterials, 27, 3675-3683.

[20]   Valentin, J.E., Stewart-Akers, A.M., Gilbert, T.W. and Badylak, S.F. (2009) Macrophage participation in the de- gradation and remodeling of ECM scaffolds. Tissue Engineering Part A, 15, 1687-1694. doi:10.1089/ten.tea.2008.0419

[21]   Badylak, S.F., Valentin, J.E., Ravindra, A.K., McCabe, G.P. and Stewart-Akers, A.M. (2008) Macrophage phe- notype as a determinant of biologic scaffold remodelling. Tissue Engineering Part A, 14, 1835-1842. doi:10.1089/ten.tea.2007.0264

[22]   Cole, P.D., Stal, D., Sharabi, S.E., Hicks, J. and Hollier, L.H. (2011) A comparative, long-term assessment of four soft tissue substitutes. Aesthetic Surgery Journal, 31, 674- 681. doi:10.1177/1090820X11415393

[23]   Bystrom, J., Evans, I., Newsson, J., Stables, M., Toor, I., Van, R.N., Crawford, M., Colville-Nash, P., Farrow, S. and Gilroy, D.W. (2008) Resolution-phase macrophages possess a unique inflammatory phenotype that is con- trolled by cAMP. Blood, 15, 4117-4127. doi:10.1182/blood-2007-12-129767

[24]   Morris, D.L., Singer, K. and Lumeng, C.N. (2011) Adi- pose tissue macrophages: Phenotypic plasticity and di- versity in lean and obese states. Current Opinion in Cli- nical Nutrition & Metabolic Care, 14, 341-346. doi:10.1097/MCO.0b013e328347970b

[25]   Capito, A.E., Tholpady, S.S., Agrawal, H., Drake, D.B. and Katz, A.J. (2012) Evaluation of host tissue integration, revascularization, and cellular infiltration within various dermal substrates. Annals of Plastic Surgery, 68, 495-500. doi:10.1097/SAP.0b013e31823b6b01

 
 
Top